Breaking News Instant updates and real-time market news.

PEGA

Pegasystems

$49.92

0.06 (0.12%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55

Pegasystems management to meet with Benchmark

Meeting to be held in Boston on December 11 hosted by Benchmark.

  • 11

    Dec

PEGA Pegasystems
$49.92

0.06 (0.12%)

04/26/18
DADA
04/26/18
INITIATION
Target $72
DADA
Buy
Pegasystems initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Pegasystems (PEGA) with a Buy rating and a price target of $72, citing the company's market leading position in the business process management and case management markets amid the crowing presence of customer relationship management technologies. Jaluria says the company continues to take market share from legacy vendors like IBM (IBM) and Oracle (ORCL) and increasing its competitive position in CRM, while driving opportunities for margin expansion.
04/26/18
04/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Omega Healthcare (OHI) initiated with a Market Perform at Raymond James. 2. HighPoint Resources (HPR) initiated with an Overweight at JPMorgan. 3. Veritone (VERI) initiated with a Buy at DA Davidson. 4. Pegasystems (PEGA) initiated with a Buy at DA Davidson. 5. Apollo Medical (AMEH) initiated with a Buy at Dougherty. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/18
MUFG
08/15/18
NO CHANGE
Target $65
MUFG
Overweight
Pegasystems headline shortfalls due to higher subscription mix, MUFG says
MUFG analyst Stephen Bersey kept his Overweight rating and $65 price target on Pegasystems after its Q2 results, saying that despite the headline miss, the company had a solid quarter. The analyst states the reported shortfalls were due to a "higher subscription mix than either the company or the Street anticipated", adding that looking through the lens of annual contract value", the growth of 31% was "impressive". Bersey adds that Pegasystems is maintaining its operating momentum.
11/07/18
MUFG
11/07/18
NO CHANGE
Target $55
MUFG
Overweight
Pegasystems earnings miss due to 'elevated subscription mix', says MUFG
MUFG analyst Stephen Bersey kept his Overweight rating and $55 price target on Pegasystems after its Q3 results, saying the EPS miss was due to "an elevated subscription mix" which dampens near term revenues. The analyst believes that the company is still seeing a "healthy demand for its offerings" and has already started to "benefit from its revenue model transition".

TODAY'S FREE FLY STORIES

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

08:00
11/19/19
11/19
08:00
11/19/19
08:00
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$30.22

2.94 (10.78%)

08:00
11/19/19
11/19
08:00
11/19/19
08:00
Options
Peloton Interactive call buyer realizes 42% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

08:00
11/19/19
11/19
08:00
11/19/19
08:00
General news
U.S. chain store sales edged up 0.5% in the November 16 week »

U.S. chain store sales…

GDDY

GoDaddy

$68.29

0.195 (0.29%)

07:58
11/19/19
11/19
07:58
11/19/19
07:58
Conference/Events
GoDaddy management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

ZEAL

Zealand Pharma

$36.13

2.7 (8.08%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Downgrade
Zealand Pharma rating change  »

Zealand Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$58.35

0.1 (0.17%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Upgrade
Ventas rating change  »

Ventas upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRPT

Freshpet

$54.47

-0.81 (-1.47%)

07:56
11/19/19
11/19
07:56
11/19/19
07:56
Conference/Events
Freshpet management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

HD

Home Depot

$238.98

1.64 (0.69%)

07:54
11/19/19
11/19
07:54
11/19/19
07:54
Recommendations
Home Depot analyst commentary  »

Home Depot selloff after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

DAVA

Endava

$44.12

0.12 (0.27%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Earnings
Endava raises FY20 adj. EPS view to GBP0.86-GBP0.89 from GBP0.85-GBP0.88 »

Cuts FY20 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

EURN

Euronav NV

$10.81

-0.18 (-1.64%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Syndicate
Euronav NV 3.75M share Secondary priced at $10.44 »

UBS acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Earnings
Endava sees Q2 adj. EPS GBP0.21-GBP0.22 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

FORM

FormFactor

$22.97

-0.24 (-1.03%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Conference/Events
FormFactor management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

EFX

Equifax

$139.44

1 (0.72%)

07:50
11/19/19
11/19
07:50
11/19/19
07:50
Hot Stocks
Equifax extends relationship with NCTUE »

Equifax has extended its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:49
11/19/19
11/19
07:49
11/19/19
07:49
Earnings
Endava reports Q1 adj. EPS GBP0.24 vs. GBP0.17 last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

ANSS

Ansys

$238.67

3.63 (1.54%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Recommendations
Ansys analyst commentary  »

Ansys price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

HP

Helmerich & Payne

$38.84

-1.72 (-4.24%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Downgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TH

Target Hospitality

$4.24

-0.26 (-5.78%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Downgrade
Target Hospitality rating change  »

Target Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRK

Scholar Rock

$7.18

-0.42 (-5.53%)

07:47
11/19/19
11/19
07:47
11/19/19
07:47
Hot Stocks
Scholar Rock announces preliminary PK, PD data from TOPAZ trial of SRK-015 »

Scholar Rock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$93.70

-0.62 (-0.66%)

07:47
11/19/19
11/19
07:47
11/19/19
07:47
Hot Stocks
Jacobs Engineering awarded $216.6M contract by U.S. FEDSIM »

Jacobs was selected by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 10

    Dec

FOR

Forestar Group

$20.04

-0.21 (-1.04%)

07:46
11/19/19
11/19
07:46
11/19/19
07:46
Conference/Events
Forestar Group management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MDCO

The Medicines Co.

$58.66

6.74 (12.98%)

, NVS

Novartis

$90.28

0.26 (0.29%)

07:46
11/19/19
11/19
07:46
11/19/19
07:46
Periodicals
Novartis holds talks about potential acquisition of Medicines Co, Bloomberg says »

Medicines Co. (MDCO) has…

MDCO

The Medicines Co.

$58.66

6.74 (12.98%)

NVS

Novartis

$90.28

0.26 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ACHN

Achillion

$6.26

0.005 (0.08%)

07:44
11/19/19
11/19
07:44
11/19/19
07:44
Hot Stocks
Achillion granted EMA PRIME designation for danicopan for PNH treatment »

Achillion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$192.91

0.38 (0.20%)

07:43
11/19/19
11/19
07:43
11/19/19
07:43
Initiation
Arista Networks initiated  »

Arista Networks initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

MYOV

Myovant Sciences

$6.02

-0.14 (-2.27%)

07:43
11/19/19
11/19
07:43
11/19/19
07:43
Hot Stocks
Myovant Sciences says primary efficacy endpoint met in Phase 3 HERO study »

Myovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXL

MaxLinear

$19.84

-0.2 (-1.00%)

07:42
11/19/19
11/19
07:42
11/19/19
07:42
Upgrade
MaxLinear rating change  »

MaxLinear upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.